Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Low ionic antiglobulin tests.

J H Ahn, R E Rosenfield, S Kochwa

    Transfusion
    |March 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    A modified low-ionic antiglobin test (LIAGT) significantly enhances serologic compatibility and screening tests. This improved LIAGT offers superior sensitivity and reduced nonspecificity for red blood cell testing.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A Randomized Phase III Trial of Anthracyclines Followed by Taxane versus Taxane Plus Carboplatin as (Neo)Adjuvant Therapy in Patients with Triple-Negative Breast Cancer: KCSG BR 15-1 PEARLY Trial.

    Annals of oncology : official journal of the European Society for Medical Oncology·2026
    Same author

    Safety and efficacy of trastuzumab biosimilar plus irinotecan or gemcitabine in patients with previously treated HER2 (ERBB2)-positive non-breast/non-gastric solid tumors: a phase II basket trial with circulating tumor DNA analysis.

    ESMO open·2023
    Same author

    Is there a clinical difference in paediatric congenital cholesteatoma according to age?

    The Journal of laryngology and otology·2022
    Same author

    Early line-probe assay using DNA specimens in patients with pulmonary TB.

    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2022
    Same author

    Potential role of CMPK1, SLC29A1, and TLE4 polymorphisms in gemcitabine-based chemotherapy in HER2-negative metastatic breast cancer patients: pharmacogenetic study results from the prospective randomized phase II study of eribulin plus gemcitabine versus paclitaxel plus gemcitabine (KCSG-BR-13-11).

    ESMO open·2021
    Same author

    Preparedness for COVID-19 infection prevention in Korea: a single-centre experience.

    The Journal of hospital infection·2020
    Same journal

    Investigation of the preanalytical stability of blood donor samples.

    Transfusion·2026
    Same journal

    The need for dried plasma-Still a national issue: Where are we and recommendations.

    Transfusion·2026
    Same journal

    Spray dried plasma manufactured from apheresis and whole blood derived plasma.

    Transfusion·2026
    Same journal

    Identification of a novel ABO*A1.01 allele with c.562C>T (p.Arg188Cys) mutation associated with A<sub>el</sub> phenotype in a Chinese individual.

    Transfusion·2026
    Same journal

    AABB survey on directed blood donation practices.

    Transfusion·2026
    Same journal

    Cost analysis considerations for red blood cell matching to mitigate alloimmunization in patients with sickle cell disease.

    Transfusion·2026
    See all related articles

    Area of Science:

    • Transfusion Medicine
    • Immunology

    Background:

    • Compatibility and screening tests are crucial in transfusion medicine.
    • Existing serologic procedures have limitations in sensitivity and specificity.

    Purpose of the Study:

    • To evaluate seven serologic procedures for compatibility and screening.
    • To identify the most effective method for red blood cell testing.

    Main Methods:

    • Investigated seven serologic procedures, optimizing serum to red cell suspension ratios.
    • Developed and tested a modified low-ionic antiglobin test (LIAGT) with reduced ionic concentration during incubation and washing.
    • Utilized low-ionic anti-IgG antiglobin reagent for agglutinability testing.

    Main Results:

    Related Experiment Videos

  • All seven procedures improved with a 4:1 serum to red cell suspension ratio.
  • The modified LIAGT demonstrated superior performance compared to the other six methods.
  • The modified LIAGT maintained extreme sensitivity for long-term frozen stored alloantiserums, likely due to IgG aggregation.

    • Conclusions:

    • The modified low-ionic antiglobin test (LIAGT) is a highly sensitive and specific method for red blood cell compatibility and screening.
    • This enhanced LIAGT offers significant advantages over previously described methods.
    • The test is particularly valuable for detecting antibodies in challenging samples, such as those with long-term frozen stored alloantiserums.